Nutritional Management Of Pcos: A Review Article

Abstract

Polycystic ovarian syndrome (PCOS) is an endocrine disorder characterized by a marked pattern of ovarian cysts, rupture of anovulation, and endocrine differences affecting women. According to figures from the World Health Organization (WHO), more than 116 million women (3.4%) are affected by PCOS worldwide. Risk factors considered include genetic, neuroendocrine, lifestyle / environmental, obesity that contribute to the development of PCOS. The pathophysiological feature of PCOS is mainly focused on hormonal dysfunction, insulin resistance and hyperandrogenism leading to damage to folliculogenesis that triggers the risk of related factors such as endometrial cancer, type II diabetes. This review highlights a brief overview of risk and pathophysiological treatment with drugs that work to relieve anovulation, infertility and clinical symptoms of PCOS.